MCAO reduced the sortilin expression in the dorsal striatum (p = 0.039), whereas the AP39 treatment reduced the expression of sortilin in the frontal cortex and in the hippocampus of the animals subjected to ischemia (p = 0.049 and p = 0.016) (Figure 8). The gene discussed is SORT1; the disease is ischemia.